C07K

Follow

Stats

Description

PEPTIDES (peptides containing -lactam rings C07D; cyclic dipeptides not having in their molecule any other peptide link than those which form their ring, e.g. piperazine-2,5-diones, C07D; ergot alkaloids of the cyclic peptide type C07D 519/02; single cell proteins, enzymes C12N; genetic engineering processes for obtaining peptides C12N 15/00)

Subclasses

Not Available
Subclass Title
1/00 General processes for the preparation of peptides
1/02 General processes for the preparation of peptides in solution
1/04 General processes for the preparation of peptides on carriers
1/06 General processes for the preparation of peptides using protecting groups or activating agents
1/08 General processes for the preparation of peptides using protecting groups or activating agents using activating agents

more results

Recent Patents

Not Available
Patent #TitleFiling DateIssue DatePatent Owner
9,370,583 Coagulation factor VII polypeptides Nov 09, 15 Jun 21, 16 NOVO NORDISK HEALTHCARE AG, NOVO NORDISK HEALTHCARE AG
9,370,584 CA6 antigen-specific cytotoxic conjugate and methods of using the same Oct 26, 10 Jun 21, 16 IMMUNOGEN, INC., IMMUNOGEN INC.
9,370,606 Scaffold-free self-organized 3D synthetic tissue Feb 16, 07 Jun 21, 16 TWO CELLS CO., LTD., TWO CELLS CO. LTD.
9,370,766 Sorbent comprising on its surface an aliphatic unit for the purification of organic molecules Sep 17, 12 Jun 21, 16 INSTRACTION GMBH, INSTRACTION GMBH
9,371,297 Macrocyclic ghrelin receptor modulators and methods of using the same Feb 08, 08 Jun 21, 16 OCERA THERAPEUTICS, INC., OCERA THERAPEUTICS, INC.
9,371,355 Process for production of fibrinogen Sep 20, 11 Jun 21, 16 OCTAPHARMA AG, OCTAPHARMA AG
9,371,356 Separation of biocomponents from manure Jun 27, 13 Jun 21, 16 OCTAPHARMA AG, Not available
9,371,357 Inhibitors of viral integrase and methods of use Mar 04, 14 Jun 21, 16 INTEGRATECH PROTEOMICS, LLC, INTEGRATECH PROTEOMICS, LLC; NATIONAL INSTITUTES OF HEALTH;
9,371,358 Tubulysin analogues Jul 18, 11 Jun 21, 16 LEIBNIZ-INSTITUT FUR PFLANZENBIOCHEMIE, LEIBNIZ-INSTITUT FUR PFLANZENBIOCHEMIE
9,371,359 Lissencephaly therapeutic agent Nov 28, 11 Jun 21, 16 OSAKA CITY UNIVERSITY, OSAKA CITY UNIVERSITY
9,371,360 Homomultivalent and heteromultivalent inhibitors of prostate specific membrane antigen (PSMA) and uses thereof Nov 30, 12 Jun 21, 16 THE JOHNS HOPKINS UNIVERSITY, THE JOHNS HOPKINS UNIVERSITY
9,371,361 Method of producing FR901228 Apr 21, 15 Jun 21, 16 ASTELLAS PHARMA INC., ASTELLAS PHARMA INC.
9,371,362 Prostate specific antigen agents and methods of using same for prostate cancer imaging Mar 15, 13 Jun 21, 16 VISEN MEDICAL, INC., VISEN MEDICAL, INC.
9,371,363 Peptides and their use Jan 28, 08 Jun 21, 16 NOVABIOTICS LIMITED, NOVABIOTICS LIMITED
9,371,364 Dual-targeted therapeutic peptide for nasopharyngeal carcinoma, nanoparticles carrying same and uses thereof Jun 07, 13 Jun 21, 16 HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY, HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY
9,371,365 Modified compstatin with peptide backbone and C-terminal modifications Feb 02, 15 Jun 21, 16 THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA, THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA
9,371,366 Influenza virus vaccines and uses thereof Dec 17, 13 Jun 21, 16 ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI, ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI
9,371,367 Selective delivery molecules and methods of use Jan 26, 16 Jun 21, 16 AVELAS BIOSCIENCES, INC., AVELAS BIOSCIENCES, INC.
9,371,368 Compositions and methods for immunomodulation in an organism Dec 11, 14 Jun 21, 16 UNIVERSITY OF CONNECTICUT, UNIVERSITY OF CONNECTICUT
9,371,369 Extended recombinant polypeptides and compositions comprising same Jan 30, 14 Jun 21, 16 AMUNIX OPERATING INC., AMUNIX OPERATING, INC.

more results

Recent Publications

Not Available
Publication #TitleFiling DatePub DatePatent Owner
2016/0175,607 SYSTEMS, METHODS AND COMPOSITIONS FOR OPTICAL STIMULATION OF TARGET CELLS Mar 07, 16 Jun 23, 16 THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY,
2016/0175,826 CATALYST AND RELATED METHODS Feb 25, 16 Jun 23, 16 ,
2016/0176,819 ASYMMETRICALLY CHARGED NIR FLUOROPHORES Dec 17, 15 Jun 23, 16 UNIVERSITY OF WASHINGTON,
2016/0176,836 BIFUNCTIONAL COMPOUNDS Oct 12, 15 Jun 23, 16 UNIVERSITY OF PITTSBURGH - OF THE COMMONWEALTH SYSTEM OF HIGHER EDUCATION,
2016/0176,852 CYANINE COMPOUNDS Feb 12, 16 Jun 23, 16 ,
2016/0176,853 Benzocyanine Compounds Dec 11, 15 Jun 23, 16 PIERCE BIOTECHNOLOGY, INC.,
2016/0176,918 COUPLING METHOD FOR PEPTIDE SYNTHESIS AT ELEVATED TEMPERATURES Dec 15, 15 Jun 23, 16 CEM CORPORATION,
2016/0176,919 CELL SPECIFIC LABELING OF NEWLY SYNTHESIZED PROTEINS Dec 22, 15 Jun 23, 16 OREGON HEALTH & SCIENCE UNIVERSITY,
2016/0176,920 MAGNETIC SEPARATION OF LIPOPROTEINS USING DEXTRAN SULFATE Dec 31, 15 Jun 23, 16 ,
2016/0176,921 METHODS OF PURIFYING RECOMBINANT PROTEINS Dec 22, 15 Jun 23, 16 ALEXION PHARMACEUTICALS, INC.,
2016/0176,922 INHIBITORS OF PROTEIN TYROSINE PHOSPHATASES Dec 18, 15 Jun 23, 16 ,
2016/0176,923 NONAPEPTIDE WITH ANTI-TUMOUR ACTIVITY Dec 14, 15 Jun 23, 16 ,
2016/0176,924 MODIFIED PEPTIDES AS POTENT INHIBITORS OF THE PSD-95/NMDA RECEPTOR INTERACTION Dec 16, 15 Jun 23, 16 UNIVERSITY OF COPENHAGEN,
2016/0176,925 MELANOCORTIN RECEPTOR LIGANDS MODIFIED WITH HYDANTOIN Feb 29, 16 Jun 23, 16 IPSEN PHARMA S.A.S.,
2016/0176,926 PEPTIDES AND RELATED MOLECULES THAT BIND TO TALL-1 Sep 21, 15 Jun 23, 16 ,
2016/0176,927 PEPTIDE FOR SUPPRESSING OSTEOCLAST DIFFERENTIATION AND USE THEREOF Oct 25, 13 Jun 23, 16 CAREGEN CO., LTD.,
2016/0176,928 Immunomodulators Dec 16, 15 Jun 23, 16 BRISTOL-MYERS SQUIBB COMPANY,
2016/0176,929 BRADYKININ RECEPTOR MODULATORS AND USE THEREOF Jun 24, 14 Jun 23, 16 ,
2016/0176,930 MU OPIOID RECEPTOR AGONIST ANALOGS OF THE ENDOMORPHINS Dec 18, 15 Jun 23, 16 THE UNITED STATES OF AMERICA AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS,
2016/0176,931 RED GENETICALLY ENCODED CALCIUM INDICATORS AND METHODS OF USE Dec 18, 15 Jun 23, 16 HOWARD HUGHES MEDICAL INSTITUTE,

more results

Patents Issued To Date - By Filing Year

Average Time to Issuance

We are sorry but your current selection exceeds the maximum number of follows () for this membership level. Upgrade to our Level for up to follows!

UPGRADE MEMBERSHIP CANCEL
We are sorry but Dashboard Viewer is not able to follow the Technologies/Sub-Technologies.